255 related articles for article (PubMed ID: 31046911)
41. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
42. [Alkaptonuria and ochronosis].
Zimmermann KG; Adolphsen P; Lenz H; Siegenthaler W
Dtsch Med Wochenschr; 1972 Feb; 97(7):242-4 passim. PubMed ID: 5058585
[No Abstract] [Full Text] [Related]
43. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review.
Ventura-Ríos L; Hernández-Díaz C; Gutiérrez-Pérez L; Bernal-González A; Pichardo-Bahena R; Cedeño-Garcidueñas AL; Pineda C
Clin Rheumatol; 2016 May; 35(5):1389-95. PubMed ID: 24647979
[TBL] [Abstract][Full Text] [Related]
44. Alkaptonuria in Russia.
Soltysova A; Kuzin A; Samarkina E; Zatkova A
Eur J Hum Genet; 2022 Feb; 30(2):237-242. PubMed ID: 34504318
[TBL] [Abstract][Full Text] [Related]
45. Alkaptonuria: Spontaneous Achilles tendon rupture: Case report.
Baca E; Kural A; Ziroglu N; Kural C
Eklem Hastalik Cerrahisi; 2019 Dec; 30(3):325-8. PubMed ID: 31650933
[TBL] [Abstract][Full Text] [Related]
46. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
[TBL] [Abstract][Full Text] [Related]
47. Glaucoma With Alkaptonuria as a Result of Pigment Accumulation.
Okutucu M; Aslan MG; Findik H; Yavuz G
J Glaucoma; 2019 Jul; 28(7):e112-e114. PubMed ID: 31274704
[TBL] [Abstract][Full Text] [Related]
48. Three-generational alkaptonuria in a non-consanguineous family.
Oexle K; Engel K; Tinschert S; Haas D; Lee-Kirsch MA
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S425-30. PubMed ID: 19096913
[TBL] [Abstract][Full Text] [Related]
49. Long-term result of arthroplasty in the treatment of a case of ochronotic arthropathy.
Karaoğlu S; Karaaslan F; Mermerkaya MU
Acta Orthop Traumatol Turc; 2016 Oct; 50(5):584-586. PubMed ID: 27817975
[TBL] [Abstract][Full Text] [Related]
50. Alkaptonuria with extensive ochronosis.
Wyre HW
Arch Dermatol; 1979 Apr; 115(4):461-3. PubMed ID: 434871
[TBL] [Abstract][Full Text] [Related]
51. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties.
Araki K; Sudo A; Hasegawa M; Uchida A
J Clin Rheumatol; 2009 Apr; 15(3):138-40. PubMed ID: 19300282
[TBL] [Abstract][Full Text] [Related]
52. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
[TBL] [Abstract][Full Text] [Related]
53. New developments in ochronosis: review of the literature.
Keller JM; Macaulay W; Nercessian OA; Jaffe IA
Rheumatol Int; 2005 Mar; 25(2):81-5. PubMed ID: 15322814
[TBL] [Abstract][Full Text] [Related]
54. Ochronotic arthritis: case reports and review of the literature.
Cetinus E; Cever I; Kural C; Erturk H; Akyildiz M
Rheumatol Int; 2005 Aug; 25(6):465-8. PubMed ID: 15580350
[TBL] [Abstract][Full Text] [Related]
55. [Important bilateral corneal astigmatism in a case of ocular ochronosis].
Ehongo A; Schrooyen M; Pereleux A
Bull Soc Belge Ophtalmol; 2005; (295):17-21. PubMed ID: 15849984
[TBL] [Abstract][Full Text] [Related]
56. [Alkaptonuria and ochronotic arthropathy. Arthroscopic and intraoperative findings in implantation of a knee joint surface replacing prosthesis].
Ramsperger R; Lubinus P; Lubinus HH
Chirurg; 1994 Nov; 65(11):1061-5. PubMed ID: 7821069
[TBL] [Abstract][Full Text] [Related]
57. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
[TBL] [Abstract][Full Text] [Related]
58. Chronic low backache and stiffness may not be due ankylosing spondylitis.
Ahmed S; Shah Z; Ali N
J Pak Med Assoc; 2010 Aug; 60(8):681-3. PubMed ID: 20726204
[TBL] [Abstract][Full Text] [Related]
59. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
[TBL] [Abstract][Full Text] [Related]
60. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
Ranganath LR; Norman BP; Gallagher JA
J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
